Page last updated: 2024-10-21

vanilmandelic acid and Apnea, Sleep

vanilmandelic acid has been researched along with Apnea, Sleep in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hedner, J1
Darpö, B1
Ejnell, H1
Carlson, J1
Caidahl, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators[NCT02058823]Phase 412 participants (Actual)Interventional2013-08-07Terminated (stopped due to budget constraints)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for vanilmandelic acid and Apnea, Sleep

ArticleYear
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications.
    The European respiratory journal, 1995, Volume: 8, Issue:2

    Topics: Blood Pressure; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Male; Metanephrine; Mi

1995